Patents by Inventor Jin-Mei Lai

Jin-Mei Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
    Patent number: 8455196
    Abstract: The preset invention relates to a biomarker for identifying the subgroup of early-stage lung adenocarcinoma patients in early-stage non-small cell lung cancer (NSCLC), which is T-lymphokine-activated killer cell-originated protein kinase (TOPK), and a therapeutic target for lung cancer.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: June 4, 2013
    Inventor: Jin-Mei Lai
  • BIOMARKER FOR IDENTIFYING SUBGROUP OF EARLY-STAGE LUNG ADENOCARCINOMA PATIENTS
    Publication number: 20120302624
    Abstract: The preset invention relates to a biomarker for identifying the subgroup of early-stage lung adenocarcinoma patients in early-stage non-small cell lung cancer (NSCLC), which is T-lymphokine-activated killer cell-originated protein kinase (TOPK), and a therapeutic target for lung cancer.
    Type: Application
    Filed: May 23, 2012
    Publication date: November 29, 2012
    Inventor: Jin-Mei Lai